BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33780691)

  • 1. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
    Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
    Ann Diagn Pathol; 2021 Jun; 52():151733. PubMed ID: 33780691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
    Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
    Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISUP Consensus Definition of Cribriform Pattern Prostate Cancer.
    van der Kwast TH; van Leenders GJ; Berney DM; Delahunt B; Evans AJ; Iczkowski KA; McKenney JK; Ro JY; Samaratunga H; Srigley JR; Tsuzuki T; Varma M; Wheeler TM; Egevad L
    Am J Surg Pathol; 2021 Aug; 45(8):1118-1126. PubMed ID: 33999555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology.
    Latour M; Amin MB; Billis A; Egevad L; Grignon DJ; Humphrey PA; Reuter VE; Sakr WA; Srigley JR; Wheeler TM; Yang XJ; Epstein JI
    Am J Surg Pathol; 2008 Oct; 32(10):1532-9. PubMed ID: 18724248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
    Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
    Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
    Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
    Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Compérat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJ
    Histopathology; 2016 Sep; 69(3):441-9. PubMed ID: 27028587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
    Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
    Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria.
    Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan CC; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
    Histopathology; 2023 May; 82(6):837-845. PubMed ID: 36645163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
    Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].
    Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI;
    Pathologe; 2016 Feb; 37(1):17-26. PubMed ID: 26809207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
    Gottipati S; Warncke J; Vollmer R; Humphrey PA
    Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gleason grading: past, present and future.
    Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
    Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.